The relevance of probiotics in therapy
DOI:
https://doi.org/10.12775/JEHS.2021.11.08.009Keywords
Probiotics, microbiota, microorganismsAbstract
Probiotics are live microorganisms that have a positive effect on human health, in particular on the intestinal microbiota. It turned out that they not only perform an important role in the intestinal microbiota, but also affect the functioning of the immune system, reduce the incidence of allergies or significantly reduce the risk of certain types of cancer. Thanks to the proven benefits of probiotics, scientists are now looking into their use in the treatment of many diseases. The examples are Helicobacter pylori infection, Irritable Bowel Syndrome and Respiratory Tract Infection, where the significant benefits of probiotics have been proved. Until recently it was thought that they were only useful in gastrointestinal diseases, but the use of probiotics in Respiratory Tract Infection shows that probiotics can also be used to treat other diseases. Further research into the impact of probiotics on therapy is highly desirable in order to match the effects of specific strains to specific diseases.
References
Barbara G, Feinle-Bisset C, Ghoshal UC, Quigley EM, Santos J, Vanner S, Vergnolle N, Zoetendal EG. The Intestinal Microenvironment and Functional Gastrointestinal Disorders. Gastroenterology. 2016;150(6):1305-1318. DOI: 10.1053/j.gastro.2016.02.028
Camilo V, Sugiyama T, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2017;22 Suppl 1. DOI: 10.1111/hel.12405
Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949-58. DOI: 10.1001/jama.2015.0954
Gong Y, Li Y, Sun Q. Probiotics improve efficacy and tolerability of triple therapy to eradicate Helicobacter pylori: a meta-analysis of randomized controlled trials. Int J Clin Exp Med. 2015;8(4):6530-6543.
Gotteland M, Brunser O, Cruchet S. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? Aliment Pharmacol Ther. 2006;23(8):1077-86. DOI: 10.1111/j.1365-2036.2006.02868.x
Guitor AK, Wright GD. Antimicrobial Resistance and Respiratory Infections. Chest. 2018;154(5):1202-1212. DOI: 10.1016/j.chest.2018.06.019
Hu, Y., Zhang, M., Lu, B. and Dai, J. Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem. Helicobacter 2016;21:349–363. DOI: 10.1111/hel.12299
Kim SK, Guevarra RB, Kim YT, Kwon J, Kim H, Cho JH, Kim HB, Lee JH. Role of Probiotics in Human Gut Microbiome-Associated Diseases. J. Microbiol. Biotechnol. 2019;29:1335-1340. DOI: 10.4014/jmb.1906.06064
King S, Glanville J, Sanders ME, Fitzgerald A, Varley D. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis. Br J Nutr. 2014;112(1):41-54. DOI: 10.1017/S0007114514000075
Kopp-Hoolihan L. Prophylactic and therapeutic uses of probiotics: a review. J Am Diet Assoc. 2001;101(2):229-38. DOI: 10.1016/S0002-8223(01)00060-8
Liu S, Hu P, Du X, Zhou T, Pei X. Lactobacillus rhamnosus GG supplementation for preventing respiratory infections in children: a meta-analysis of randomized, placebo-controlled trials. Indian Pediatr. 2013;50(4):377-81. DOI: 10.1007/s13312-013-0123-z
Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712-721. DOI: 10.1016/j.cgh.2012.02.029
Nagy, P., Johansson, S. & Molloy-Bland, M. Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA. Gut Pathog 2016;8:8. DOI: 10.1186/s13099-016-0091-7
O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128(3):541-51. DOI: 10.1053/j.gastro.2004.11.050
Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, Dubuquoy C, Merour E, Geboes K, Chamaillard M, Ouwehand A, Leyer G, Carcano D, Colombel JF, Ardid D, Desreumaux P. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med. 2007;13(1):35-7. DOI: 10.1038/nm1521
Sitas F. Twenty five years since the first prospective study by Forman et al. (1991) on Helicobacter pylori and stomach cancer risk. Cancer Epidemiol. 2016;41:159-64. DOI: 10.1016/j.canep.2016.02.002
Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med. 2019;25(5):716-729. DOI: 10.1038/s41591-019-0439-x
Tapparel C, Siegrist F, Petty TJ, Kaiser L. Picornavirus and enterovirus diversity with associated human diseases. Infect Genet Evol. 2013;14:282-93. DOI: 10.1016/j.meegid.2012.10.016
Wall GC, Bryant GA, Bottenberg MM, Maki ED, Miesner AR. Irritable bowel syndrome: a concise review of current treatment concepts. World J Gastroenterol. 2014;20(27):8796-806. DOI: 10.3748/wjg.v20.i27.8796
Williams NT. Probiotics. Am J Health Syst Pharm. 2010;67(6):449-58. DOI: 10.2146/ajhp090168
Evridiki K. Vouloumanou, Gregory C. Makris, Drosos E. Karageorgopoulos, Matthew E. Falagas. Probiotics for the prevention of respiratory tract infections: a systematic review. Int. J. Antimicrob. Agents. 2009;34(3):197. DOI: 10.1016/j.ijantimicag.2008.11.005
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 454
Number of citations: 0
